Important notice

Unavailability of our Web site

We will be carrying a maintenance from 4:45 p.m. to 5:30 p.m. on December 8. Our website will be unavailable during this period. Thank you for your understanding.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114437
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114435

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114436
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114434

Bimzelx

Exceptional medication
  • Active ingredient(s):
    bimekizumab (plaque psoriasis)
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 160 mg/mL (1 mL) DIN : 2525267
    • Subcutaneous Injectable Solution syringe 160 mg /mL (2 mL) DIN : 2553619
    • Subcutaneous Injectable Solution (pen) 160 mg/mL (1 mL) DIN : 2525275
    • Subcutaneous Injectable Solution (pen) 160 mg /mL (2 mL) DIN : 2553627

JAMP Cabergoline

Exceptional medication
  • Active ingredient(s):
    cabergoline
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 0.5 mg DIN : 2549611

Ixifi

Exceptional medication
  • Active ingredient(s):
    infliximab
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2523191

Remdantry

Exceptional medication
  • Active ingredient(s):
    infliximab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2419475

Apo-Nilotinib

Exceptional medication
  • Active ingredient(s):
    nilotinib
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Capsule 150 mg DIN : 2550881
    • Capsule 200 mg DIN : 2550903

M-Pirfenidone

Exceptional medication
  • Active ingredient(s):
    pirfenidone
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    • Tablet 267 mg DIN : 2550644
    • Tablet 801 mg DIN : 2550652

Tyenne

Exceptional medication
  • Active ingredient(s):
    tocilizumab
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 162 mg/0.9 mL DIN : 2552493
    • Intravenous Perfusion Solution 20 mg/mL (10 mL) DIN : 2552469
    • Intravenous Perfusion Solution 20 mg/mL (20 mL) DIN : 2552477
    • Intravenous Perfusion Solution 20 mg/mL (4 mL) DIN : 2552450
    • Subcutaneous Injectable Solution (pen) 162 mg/0.9 mL DIN : 2552485

Epidiolex

Exceptional medication
  • Active ingredient(s):
    cannabidiol
  • Manufactured by:
    Jazz Pharmaceuticals Canada (Jazz)
  • Strength and dosage form:
    Oral Solution 100 mg /mL (100 mL) DIN : 2543079
Page 135 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.